Inappropriate Grading of Adverse Events in Cancer Clinical Trials—Reply

JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.5871
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)